
Novel селективный ингибитор of TET1 transcription and 5-hydroxymethylcytosine (5hmC) modification, effectively inhibiting клетка viability in AML with high expression of TET1
Novel selective inhibitor of TET1 transcription and 5-hydroxymethylcytosine (5hmC) modification, effectively inhibiting cell viability in AML with high expression of TET1
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.